JP2000513352A5 - - Google Patents

Download PDF

Info

Publication number
JP2000513352A5
JP2000513352A5 JP1998502632A JP50263298A JP2000513352A5 JP 2000513352 A5 JP2000513352 A5 JP 2000513352A5 JP 1998502632 A JP1998502632 A JP 1998502632A JP 50263298 A JP50263298 A JP 50263298A JP 2000513352 A5 JP2000513352 A5 JP 2000513352A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998502632A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000513352A (ja
JP4227195B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL1997/000210 external-priority patent/WO1997049423A2/en
Publication of JP2000513352A publication Critical patent/JP2000513352A/ja
Publication of JP2000513352A5 publication Critical patent/JP2000513352A5/ja
Application granted granted Critical
Publication of JP4227195B2 publication Critical patent/JP4227195B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP50263298A 1996-06-24 1997-06-24 リポソームインフルエンザワクチンの組成物および方法 Expired - Fee Related JP4227195B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2006396P 1996-06-24 1996-06-24
US60/020,063 1996-06-24
PCT/IL1997/000210 WO1997049423A2 (en) 1996-06-24 1997-06-24 Liposomal influenza vaccine composition and method

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008149959A Division JP2008260779A (ja) 1996-06-24 2008-06-06 リポソームインフルエンザワクチンの組成物および方法

Publications (3)

Publication Number Publication Date
JP2000513352A JP2000513352A (ja) 2000-10-10
JP2000513352A5 true JP2000513352A5 (cg-RX-API-DMAC10.html) 2005-02-10
JP4227195B2 JP4227195B2 (ja) 2009-02-18

Family

ID=21796541

Family Applications (2)

Application Number Title Priority Date Filing Date
JP50263298A Expired - Fee Related JP4227195B2 (ja) 1996-06-24 1997-06-24 リポソームインフルエンザワクチンの組成物および方法
JP2008149959A Withdrawn JP2008260779A (ja) 1996-06-24 2008-06-06 リポソームインフルエンザワクチンの組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008149959A Withdrawn JP2008260779A (ja) 1996-06-24 2008-06-06 リポソームインフルエンザワクチンの組成物および方法

Country Status (8)

Country Link
US (1) US5919480A (cg-RX-API-DMAC10.html)
EP (1) EP0954286B1 (cg-RX-API-DMAC10.html)
JP (2) JP4227195B2 (cg-RX-API-DMAC10.html)
AT (1) ATE422352T1 (cg-RX-API-DMAC10.html)
AU (1) AU731705B2 (cg-RX-API-DMAC10.html)
CA (1) CA2258878C (cg-RX-API-DMAC10.html)
DE (1) DE69739253D1 (cg-RX-API-DMAC10.html)
WO (1) WO1997049423A2 (cg-RX-API-DMAC10.html)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7731972B1 (en) * 2000-02-04 2010-06-08 Vlaams Interuniversitair Instituut Voor Biotechnologie Immunoprotective influenza antigen and its use in vaccination
EP1027071A2 (en) * 1997-10-31 2000-08-16 Cistron Biotechnology Inc. Encapsulated immunomodulators useful as vaccine adjuvants
AT407958B (de) * 1999-02-11 2001-07-25 Immuno Ag Inaktivierte influenza-virus-vakzine zur nasalen oder oralen applikation
CA2428103C (en) 2000-11-07 2015-06-09 Immunovaccine Technologies Inc. Vaccines with enhanced immune response and methods for their preparation
WO2002040504A2 (en) * 2000-11-15 2002-05-23 The Government Of The United States Of America, Represnted By The Secretary, Department Of Health And Human Services Sol-fusin: use of gp64-6his to catalyze membrane fusion
TWI228420B (en) * 2001-05-30 2005-03-01 Smithkline Beecham Pharma Gmbh Novel vaccine composition
EP1404298A2 (en) * 2001-06-25 2004-04-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem A method for preparation of vesicles loaded with biological material and different uses thereof
ATE431745T1 (de) * 2001-07-05 2009-06-15 Ltb4 Sweden Ab Ltb4 als adjuvans für impfstoffe
CN1665487A (zh) * 2002-07-03 2005-09-07 埃弗顿有限公司 脂质体疫苗
US20040247661A1 (en) * 2002-07-03 2004-12-09 Dov Michaeli Liposomal vaccine
US20050169979A1 (en) * 2002-07-03 2005-08-04 Dov Michaeli Liposomal vaccine
US9028863B2 (en) 2003-04-25 2015-05-12 The Penn State Research Foundation Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
US20060286161A1 (en) * 2003-05-09 2006-12-21 Steffen Panzner Injectable liposomal depots for delivering active ingredients
RU2390351C2 (ru) * 2003-08-11 2010-05-27 Дзе Ресерч Фаундейшн Фо Макробайал Дизизес Оф Осака Юниверсити Вакцина против вируса гриппа для введения через слизистую и способ предотвращения гриппа
CN1893925B (zh) * 2003-08-21 2011-04-27 利普泰克有限公司 树突细胞的体内靶向
FR2868951B1 (fr) * 2004-04-15 2006-07-21 Ethypharm Sa Compositions contenant ds vesicules lamellaires incorporant un principe actif peu soluble dans l'eau et produits intermediaires utiles pour leur preparation
US20050260260A1 (en) * 2004-05-19 2005-11-24 Edward Kisak Liposome compositions for the delivery of macromolecules
JP2008526870A (ja) * 2005-01-05 2008-07-24 フイラデルフイア・ヘルス・アンド・エデユケーシヨン・コーポレーシヨン 送達ビヒクル、生体作用活性物質およびウイルスワクチン
CA2523032A1 (en) 2005-10-07 2007-04-07 Immunovaccine Technologies Inc. Vaccines for cancer therapy
AU2008303023B2 (en) 2007-09-27 2014-01-09 Immunovaccine Technologies Inc. Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo
US20100209452A1 (en) * 2007-10-03 2010-08-19 Immunovaccine Technologies, Inc Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
WO2009090650A2 (en) * 2008-01-16 2009-07-23 Ben-Gurion University Of The Negev Research And Development Authority Vaccine for alzheimer's disease
US20110070298A1 (en) 2008-06-05 2011-03-24 Immunovaccine Technologies Inc. Compositions Comprising Liposomes, An Antigen, A Polynucleotide and A Carrier Comprising a Continuous Phase of a Hydrophobic Substance
JP5681626B2 (ja) 2008-07-14 2015-03-11 ポリーペイド リミテッドPolypid Ltd. 徐放性薬剤キャリア組成物
EP2391370B1 (en) 2009-02-02 2015-06-03 Galmed Research and Development Ltd. Methods and compositions for treating alzheimer's disease
CA2803282C (en) 2009-07-06 2018-05-01 David E. Anderson Methods for preparing vesicles and formulations produced therefrom
EP2451950B9 (en) 2009-07-06 2016-11-23 Variation Biotechnologies Inc. Methods for preparing vesicles and formulations produced therefrom
US8992979B2 (en) 2009-07-14 2015-03-31 Polypid Ltd. Sustained-release drug carrier composition
CA2775564A1 (en) * 2009-10-09 2011-04-14 New York Blood Center, Inc. Immunopotentiator-linked oligomeric influenza immunogenic compositions
CN102892406B (zh) 2010-01-19 2015-04-08 波利皮得有限公司 缓释核酸基质组合物
JP6119030B2 (ja) * 2010-07-06 2017-04-26 ヴァリエーション バイオテクノロジーズ インコーポレイテッド インフルエンザを治療するための組成物及び方法
BR112013018074A2 (pt) 2011-01-13 2020-12-01 Variation Biotechnologies, Inc. métodos para a preparação de vesículas e formulações produzidas a partir dessas
BR112013017939B1 (pt) 2011-01-13 2022-11-16 Variation Biotechnologies Inc Composição imunogênica liofilizada termoestável, uso e método para preparação da mesma
US10105435B2 (en) 2011-10-06 2018-10-23 Immunovaccine Technologies Inc. Liposome compositions comprising an adjuvant that activates or increases the activity of TLR2 and uses thereof
CA2890084C (en) 2011-11-18 2021-05-04 Maura Ellen Campbell Synthetic derivatives of mpl and uses thereof
CA2894442C (en) 2012-01-12 2020-01-21 Variation Biotechnologies Inc. Compositions and methods for treating viral infections
CA2894467A1 (en) 2012-01-27 2013-08-01 Variation Biotechnologies Inc. Methods for preparing thermostable compositions comprising a lipid component and thermolabile therapeutic agents
CN103736090B (zh) * 2014-01-27 2016-03-02 中国医学科学院医学生物学研究所 甲磺酸去铁胺佐剂及含甲磺酸去铁胺佐剂的疫苗
CN110151702A (zh) * 2019-06-24 2019-08-23 昆明医科大学 聚乙二醇修饰流感疫苗脂质体及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117113A (en) * 1974-06-25 1978-09-26 National Research Development Corporation Immunological preparations
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4235877A (en) * 1979-06-27 1980-11-25 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
US4426330A (en) 1981-07-20 1984-01-17 Lipid Specialties, Inc. Synthetic phospholipid compounds
US4534899A (en) 1981-07-20 1985-08-13 Lipid Specialties, Inc. Synthetic phospholipid compounds
JPH0720857B2 (ja) * 1988-08-11 1995-03-08 テルモ株式会社 リポソームおよびその製法
NZ230423A (en) * 1988-08-25 1993-08-26 Liposome Co Inc A dosage form comprising an antigen and a multilamellar liposome comprising dimyristolyphosphatidylcholine (dmpc) and cholesterol
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
JP3037994B2 (ja) * 1989-11-02 2000-05-08 テルモ株式会社 リポソーム表面への蛋白質吸着抑制剤
JP3220180B2 (ja) * 1991-05-23 2001-10-22 三菱化学株式会社 薬剤含有タンパク質結合リポソーム
ZA934890B (en) * 1992-07-08 1994-04-14 Schering Corp Use of Gm-CSF as a vaccine adjuvant
US6326353B1 (en) * 1993-03-23 2001-12-04 Sequus Pharmaceuticals, Inc. Enhanced circulation effector composition and method
ATE179599T1 (de) * 1993-08-06 1999-05-15 Opperbas Holding Bv Verfahren zur hohen beladung von vesikeln mit biopolymeren substanzen
AUPM500494A0 (en) * 1994-04-12 1994-05-05 Minister For Agriculture & Rural Affairs For The State Of New South Wales, The Composition for use in increasing mucosal immunity

Similar Documents

Publication Publication Date Title
JP2001504701A5 (cg-RX-API-DMAC10.html)
JP2000502280A5 (cg-RX-API-DMAC10.html)
JP2000501018A5 (cg-RX-API-DMAC10.html)
JP2000507453A5 (cg-RX-API-DMAC10.html)
JP2000504881A5 (cg-RX-API-DMAC10.html)
JP2000501324A5 (cg-RX-API-DMAC10.html)
JP2001506303A5 (cg-RX-API-DMAC10.html)
JP2000502472A5 (cg-RX-API-DMAC10.html)
JP2000501338A5 (cg-RX-API-DMAC10.html)
JP2000500874A5 (cg-RX-API-DMAC10.html)
JP2001524277A5 (cg-RX-API-DMAC10.html)
JP2000502485A5 (cg-RX-API-DMAC10.html)
JP2000502425A5 (cg-RX-API-DMAC10.html)
JP2000502568A5 (cg-RX-API-DMAC10.html)
JP2000500912A5 (cg-RX-API-DMAC10.html)
JP2000502570A5 (cg-RX-API-DMAC10.html)
JP2000513352A5 (cg-RX-API-DMAC10.html)
JP2000501876A5 (cg-RX-API-DMAC10.html)
JP2000516592A5 (cg-RX-API-DMAC10.html)
JP2002511979A5 (cg-RX-API-DMAC10.html)
JP2001502411A5 (cg-RX-API-DMAC10.html)
JP2000501229A5 (cg-RX-API-DMAC10.html)
JP2000502316A5 (cg-RX-API-DMAC10.html)
JP2000500857A5 (cg-RX-API-DMAC10.html)
JP2000502714A5 (cg-RX-API-DMAC10.html)